Peroxitech
PrivateLast Round
Series A
Dec 13, 2022
Est. Valuation
$44M
Total Funding Raised
$25.6M
Company Overview
Peroxitech operates in Healthcare & Life Sciences and is based in Philadelphia, Pennsylvania. Its latest recorded funding round was a Series A round in December 2022.
Peroxitech is a biotechnology company that develops novel peptide drugs to treat and prevent acute lung injury by targeting the cytokine storm cascade.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Peroxitech Comparables
Compare Peroxitech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vasomune Therapeutics | 82% | |
| APEPTICO Forschung und Entwicklung GmbH | 81% | |
| Chrysalis BioTherapeutics, Inc. | 76% |
For institutional investors. Book with your work email.
Peroxitech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 13, 2022 | ||||
| Grant | Aug 30, 2022 | ||||
| Seed | May 12, 2021 | ||||
| Grant | Jun 1, 2020 |
For institutional investors. Book with your work email.
Peroxitech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Perceptive Advisors | Series A |
| NIH RADx | Grant |
| Xontogeny | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 13, 2022
$25M round led by Perceptive Advisors
For institutional investors. Book with your work email.
Peroxitech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Peroxitech's valuation, stock price, and market status.
Is Peroxitech a public or private company?
Peroxitech is a private company.
What is the current stock price of Peroxitech?
Peroxitech is a private company, so its shares have no public market price. Caplight tracks Peroxitech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Peroxitech worth (valuation)?
Peroxitech's valuation is estimated at $44.0M based on funding round data.
Can I buy Peroxitech stock?
Peroxitech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Peroxitech's last funding round?
Peroxitech's most recent funding round was Series A on December 13, 2022.
Who are the main investors in Peroxitech?
Key investors in Peroxitech include Perceptive Advisors, Xontogeny.
Will Peroxitech IPO soon?
No public IPO plans have been announced for Peroxitech.
How can I track Peroxitech secondary market activity?
Caplight tracks bids, offers, and trades in Peroxitech's shares on secondary markets.